{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:51:31Z","timestamp":1790254291610,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fond de la recherche scientifique et m\u00e9dicale","award":["FRSM-IREC88A6"],"award-info":[{"award-number":["FRSM-IREC88A6"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00223-019-00655-5","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T03:02:56Z","timestamp":1580958176000},"page":"494-508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim\/oim Mice"],"prefix":"10.1007","volume":"106","author":[{"given":"Micka\u00ebl","family":"Cardinal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Dessain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Roels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Lafont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Ominsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Devogelaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Chappard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Mabilleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ammann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Nyssen-Behets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Manicourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,6]]},"reference":[{"issue":"9418","key":"655_CR1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","volume":"363","author":"F Rauch","year":"2004","unstructured":"Rauch F, Glorieux FH (2004) Osteogenesis imperfecta. The Lancet 363(9418):1377\u20131385","journal-title":"The Lancet"},{"issue":"9","key":"655_CR2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrendo.2011.81","volume":"7","author":"A Forlino","year":"2011","unstructured":"Forlino A, Cabral WA, Barnes AM, Marini JC (2011) New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol 7(9):540\u2013557","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"655_CR3","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","volume":"164A","author":"FS Van Dijk","year":"2014","unstructured":"Van Dijk FS, Sillence DO (2014) Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A 164A(6):1470\u20131481","journal-title":"Am J Med Genet A"},{"issue":"7","key":"655_CR4","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/ppul.24039","volume":"53","author":"A LoMauro","year":"2018","unstructured":"LoMauro A, Fraschini P, Pochintesta S, Romei M, D'Angelo MG, Aliverti A (2018) Ribcage deformity and the altered breathing pattern in children with osteogenesis imperfecta. Pediatr Pulmonol 53(7):964\u2013972","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"655_CR5","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/jcp.49.8.627","volume":"49","author":"SJ McAllion","year":"1996","unstructured":"McAllion SJ, Paterson CR (1996) Causes of death in osteogenesis imperfecta. J Clin Pathol 49(8):627\u2013630","journal-title":"J Clin Pathol"},{"issue":"2","key":"655_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ocl.2018.10.003","volume":"50","author":"JM Franzone","year":"2019","unstructured":"Franzone JM, Shah SA, Wallace MJ, Kruse RW (2019) Osteogenesis imperfecta: a pediatric orthopedic perspective. Orthop Clin North Am 50(2):193\u2013209","journal-title":"Orthop Clin North Am"},{"issue":"2","key":"655_CR7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11154-008-9074-4","volume":"9","author":"MS Cheung","year":"2008","unstructured":"Cheung MS, Glorieux FH (2008) Osteogenesis Imperfecta: update on presentation and management. Rev Endocr Metab Disord 9(2):153\u2013160","journal-title":"Rev Endocr Metab Disord"},{"key":"655_CR8","first-page":"CD005088","volume":"10","author":"K Dwan","year":"2016","unstructured":"Dwan K, Phillipi CA, Steiner RD, Basel D (2016) Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev 10:CD005088","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"655_CR9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1359\/jbmr.080208","volume":"23","author":"AH Tashjian Jr","year":"2008","unstructured":"Tashjian AH Jr, Goltzman D (2008) On the interpretation of rat carcinogenicity studies for human PTH(1\u201334) and human PTH(1\u201384). J Bone Miner Res 23(6):803\u2013811","journal-title":"J Bone Miner Res"},{"key":"655_CR10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.yrtph.2016.08.010","volume":"81","author":"L Chouinard","year":"2016","unstructured":"Chouinard L, Felx M, Mellal N, Varela A, Mann P, Jolette J, Samadfam R, Smith SY, Locher K, Buntich S, Ominsky MS, Pyrah I, Boyce RW (2016) Carcinogenicity risk assessment of romosozumab: a review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study. Regul Toxicol Pharmacol 81:212\u2013222","journal-title":"Regul Toxicol Pharmacol"},{"issue":"5","key":"655_CR11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1210\/er.2011-1060","volume":"33","author":"HZ Ke","year":"2012","unstructured":"Ke HZ, Richards WG, Li X, Ominsky MS (2012) Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases. Endocr Rev 33(5):747\u2013783","journal-title":"Endocr Rev"},{"issue":"2","key":"655_CR12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.3074","volume":"19","author":"R Baron","year":"2013","unstructured":"Baron R, Kneissel M (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 19(2):179\u2013192","journal-title":"Nat Med"},{"issue":"5","key":"655_CR13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","volume":"370","author":"MR McClung","year":"2014","unstructured":"McClung MR, Grauer A, Boonen S, Bolognese MA, Brown JP, Diez-Perez A, Langdahl BL, Reginster JY, Zanchetta JR, Wasserman SM, Katz L, Maddox J, Yang YC, Libanati C, Bone HG (2014) Romosozumab in postmenopausal women with low bone mineral density. N Engl J Med 370(5):412\u2013420","journal-title":"N Engl J Med"},{"issue":"16","key":"655_CR14","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, Hofbauer LC, Lau E, Lewiecki EM, Miyauchi A, Zerbini CA, Milmont CE, Chen L, Maddox J, Meisner PD, Libanati C, Grauer A (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375(16):1532\u20131543","journal-title":"N Engl J Med"},{"key":"655_CR15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bone.2014.06.015","volume":"66","author":"A Roschger","year":"2014","unstructured":"Roschger A, Roschger P, Keplingter P, Klaushofer K, Abdullah S, Kneissel M, Rauch F (2014) Effect of sclerostin antibody treatment in a mouse model of severe osteogenesis imperfecta. Bone 66:182\u2013188","journal-title":"Bone"},{"issue":"1","key":"655_CR16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jbmr.1717","volume":"28","author":"BP Sinder","year":"2013","unstructured":"Sinder BP, Eddy MM, Ominsky MS, Caird MS, Marini JC, Kozloff KM (2013) Sclerostin antibody improves skeletal parameters in a Brtl\/+ mouse model of osteogenesis imperfecta. J Bone Miner Res 28(1):73\u201380","journal-title":"J Bone Miner Res"},{"issue":"8","key":"655_CR17","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00198-014-2737-y","volume":"25","author":"BP Sinder","year":"2014","unstructured":"Sinder BP, White LE, Salemi JD, Ominsky MS, Caird MS, Marini JC, Kozloff KM (2014) Adult Brtl\/+ mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strength. Osteoporos Int 25(8):2097\u20132107","journal-title":"Osteoporos Int"},{"key":"655_CR18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bone.2014.10.012","volume":"71","author":"BP Sinder","year":"2015","unstructured":"Sinder BP, Salemi JD, Ominsky MS, Caird MS, Marini JC, Kozloff KM (2015) Rapidly growing Brtl\/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment. Bone 71:115\u2013123","journal-title":"Bone"},{"issue":"10","key":"655_CR19","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/jbmr.2198","volume":"29","author":"CM Jacobsen","year":"2014","unstructured":"Jacobsen CM, Barber LA, Ayturk UM, Roberts HJ, Deal LE, Schwartz MA, Weis M, Eyre D, Zurakowski D, Robling AG, Warman ML (2014) Targeting the LRP5 pathway improves bone properties in a mouse model of osteogenesis imperfecta. J Bone Miner Res 29(10):2297\u20132306","journal-title":"J Bone Miner Res"},{"issue":"5","key":"655_CR20","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/jbmr.2776","volume":"31","author":"I Grafe","year":"2016","unstructured":"Grafe I, Alexander S, Yang T, Lietman C, Homan EP, Munivez E, Chen Y, Jiang MM, Bertin T, Dawson B, Asuncion F, Ke HZ, Ominsky MS, Lee B (2016) Sclerostin antibody treatment improves the bone phenotype of Crtap(-\/-) mice, a model of recessive osteogenesis imperfecta. J Bone Miner Res 31(5):1030\u20131040","journal-title":"J Bone Miner Res"},{"issue":"15","key":"655_CR21","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1093\/hmg\/ddu117","volume":"23","author":"KS Joeng","year":"2014","unstructured":"Joeng KS, Lee YC, Jiang MM, Bertin TK, Chen Y, Abraham AM, Ding H, Bi X, Ambrose CG, Lee BH (2014) The swaying mouse as a model of osteogenesis imperfecta caused by WNT1 mutations. Hum Mol Genet 23(15):4035\u20134042","journal-title":"Hum Mol Genet"},{"issue":"7","key":"655_CR22","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1172\/JCI92617","volume":"127","author":"KS Joeng","year":"2017","unstructured":"Joeng KS, Lee YC, Lim J, Chen Y, Jiang MM, Munivez E, Ambrose C, Lee BH (2017) Osteocyte-specific WNT1 regulates osteoblast function during bone homeostasis. J Clin Invest 127(7):2678\u20132688","journal-title":"J Clin Invest"},{"issue":"5","key":"655_CR23","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1073\/pnas.90.5.1701","volume":"90","author":"SD Chipman","year":"1993","unstructured":"Chipman SD, Sweet HO, McBride DJ Jr, Davisson MT, Marks SC Jr, Shuldiner AR, Wenstrup RJ, Rowe DW, Shapiro JR (1993) Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc Natl Acad Sci USA 90(5):1701\u20131705","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"655_CR24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.bone.2007.12.215","volume":"42","author":"SM Carleton","year":"2008","unstructured":"Carleton SM, McBride DJ, Carson WL, Huntington CE, Twenter KL, Rolwes KM, Winkelmann CT, Morris JS, Taylor JF, Phillips CL (2008) Role of genetic background in determining phenotypic severity throughout postnatal development and at peak bone mass in Col1a2 deficient mice (oim). Bone 42(4):681\u2013694","journal-title":"Bone"},{"issue":"2","key":"655_CR25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s002230010045","volume":"69","author":"NP Camacho","year":"2001","unstructured":"Camacho NP, Raggio CL, Doty SB, Root L, Zraick V, Ilg WA, Toledano TR, Boskey AL (2001) A controlled study of the effects of alendronate in a growing mouse model of osteogenesis imperfecta. Calcif Tissue Int 69(2):94\u2013101","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"655_CR26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bone.2004.10.006","volume":"36","author":"BM Misof","year":"2005","unstructured":"Misof BM, Roschger P, Baldini T, Raggio CL, Zraick V, Root L, Boskey AL, Klaushofer K, Fratzl P, Camacho NP (2005) Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse. Bone 36(1):150\u2013158","journal-title":"Bone"},{"issue":"7","key":"655_CR27","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.exphem.2010.04.008","volume":"38","author":"M Mehrotra","year":"2010","unstructured":"Mehrotra M, Rosol M, Ogawa M, Larue AC (2010) Amelioration of a mouse model of osteogenesis imperfecta with hematopoietic stem cell transplantation: microcomputed tomography studies. Exp Hematol 38(7):593\u2013602","journal-title":"Exp Hematol"},{"issue":"3","key":"655_CR28","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2010-05-287565","volume":"117","author":"M Vanleene","year":"2011","unstructured":"Vanleene M, Saldanha Z, Cloyd KL, Jell G, Bou-Gharios G, Bassett JH, Williams GR, Fisk NM, Oyen ML, Stevens MM, Guillot PV, Shefelbine SJ (2011) Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties. Blood 117(3):1053\u20131060","journal-title":"Blood"},{"key":"655_CR29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bone.2019.04.011","volume":"124","author":"M Cardinal","year":"2019","unstructured":"Cardinal M, Tys J, Roels T, Lafont S, Ominsky MS, Devogelaer JP, Chappard D, Mabilleau G, Ammann P, Nyssen-Behets C, Manicourt DH (2019) Sclerostin antibody reduces long bone fractures in the oim\/oim model of osteogenesis imperfecta. Bone 124:137\u2013147","journal-title":"Bone"},{"issue":"6","key":"655_CR30","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s10439-013-0793-7","volume":"41","author":"X Yao","year":"2013","unstructured":"Yao X, Carleton SM, Kettle AD, Melander J, Phillips CL, Wang Y (2013) Gender-dependence of bone structure and properties in adult osteogenesis imperfecta murine model. Ann Biomed Eng 41(6):1139\u20131149","journal-title":"Ann Biomed Eng"},{"issue":"4","key":"655_CR31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1258\/la.2010.009085","volume":"44","author":"N Cesarovic","year":"2010","unstructured":"Cesarovic N, Nicholls F, Rettich A, Kronen P, Hassig M, Jirkof P, Arras M (2010) Isoflurane and sevoflurane provide equally effective anaesthesia in laboratory mice. Lab Anim 44(4):329\u2013336","journal-title":"Lab Anim"},{"issue":"1","key":"655_CR32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1601-6343.2009.01468.x","volume":"13","author":"MA Cornelis","year":"2010","unstructured":"Cornelis MA, Mahy P, Devogelaer JP, De Clerck HJ, Nyssen-Behets C (2010) Does orthodontic loading influence bone mineral density around titanium miniplates? An experimental study in dogs. Orthod Craniofac Res 13(1):21\u201327","journal-title":"Orthod Craniofac Res"},{"issue":"1","key":"655_CR33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28(1):2\u201317","journal-title":"J Bone Miner Res"},{"issue":"6","key":"655_CR34","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00223-001-2048-0","volume":"70","author":"G Boivin","year":"2002","unstructured":"Boivin G, Meunier PJ (2002) The degree of mineralization of bone tissue measured by computerized quantitative contact microradiography. Calcif Tissue Int 70(6):503\u2013511","journal-title":"Calcif Tissue Int"},{"issue":"9","key":"655_CR35","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1359\/jbmr.070607","volume":"22","author":"P Ammann","year":"2007","unstructured":"Ammann P, Badoud I, Barraud S, Dayer R, Rizzoli R (2007) Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength. J Bone Miner Res 22(9):1419\u20131425","journal-title":"J Bone Miner Res"},{"key":"655_CR36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/9780470942390.mo130027","volume":"3","author":"L Smith","year":"2013","unstructured":"Smith L, Bigelow EM, Jepsen KJ (2013) Systematic evaluation of skeletal mechanical function. Curr Protoc Mouse Biol 3:39\u201367","journal-title":"Curr Protoc Mouse Biol"},{"issue":"1","key":"655_CR37","first-page":"43","volume":"1","author":"P Ammann","year":"2000","unstructured":"Ammann P, Bonjour JP, Rizzoli R (2000) Essential amino acid supplements increase muscle weight, bone mass and bone strength in adult osteoporotic rats. J Musculoskelet Neuronal Interact 1(1):43\u201344","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"21","key":"655_CR38","doi-asserted-by":"crossref","first-page":"12941","DOI":"10.1016\/S0021-9258(18)90635-6","volume":"259","author":"T Pihlajaniemi","year":"1984","unstructured":"Pihlajaniemi T, Dickson LA, Pope FM, Korhonen VR, Nicholls A, Prockop DJ, Myers JC (1984) Osteogenesis imperfecta: cloning of a pro-alpha 2(I) collagen gene with a frameshift mutation. J Biol Chem 259(21):12941\u201312944","journal-title":"J Biol Chem"},{"issue":"2","key":"655_CR39","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1359\/jbmr.1999.14.2.264","volume":"14","author":"NP Camacho","year":"1999","unstructured":"Camacho NP, Hou L, Toledano TR, Ilg WA, Brayton CF, Raggio CL, Root L, Boskey AL (1999) The material basis for reduced mechanical properties in oim mice bones. J Bone Miner Res 14(2):264\u2013272","journal-title":"J Bone Miner Res"},{"issue":"5","key":"655_CR40","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1210\/endo.143.5.8807","volume":"143","author":"I Kalajzic","year":"2002","unstructured":"Kalajzic I, Terzic J, Rumboldt Z, Mack K, Naprta A, Ledgard F, Gronowicz G, Clark SH, Rowe DW (2002) Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse. Endocrinology 143(5):1594\u20131601","journal-title":"Endocrinology"},{"issue":"3","key":"655_CR41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s00223-007-9045-x","volume":"81","author":"E Miller","year":"2007","unstructured":"Miller E, Delos D, Baldini T, Wright TM, Pleshko Camacho N (2007) Abnormal mineral-matrix interactions are a significant contributor to fragility in oim\/oim bone. Calcif Tissue Int 81(3):206\u2013214","journal-title":"Calcif Tissue Int"},{"key":"655_CR42","first-page":"1511","volume-title":"3rd edn","author":"D Rowe","year":"2008","unstructured":"Rowe D (2008) Osteogenesis imperfecta in principles of bone biology. In: Bilezikian JP, Raisz LG, Martin TJ (eds) 3rd edn. Elsevier, Amsterdam, pp 1511\u20131531"},{"issue":"5","key":"655_CR43","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1203\/00006450-200211000-00010","volume":"52","author":"EA McCarthy","year":"2002","unstructured":"McCarthy EA, Raggio CL, Hossack MD, Miller EA, Jain S, Boskey AL, Camacho NP (2002) Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model. Pediatr Res 52(5):660\u2013670","journal-title":"Pediatr Res"},{"issue":"2","key":"655_CR44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/03008200903108472","volume":"51","author":"R Bargman","year":"2010","unstructured":"Bargman R, Huang A, Boskey AL, Raggio C, Pleshko N (2010) RANKL inhibition improves bone properties in a mouse model of osteogenesis imperfecta. Connect Tissue Res 51(2):123\u2013131","journal-title":"Connect Tissue Res"},{"issue":"3","key":"655_CR45","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00198-011-1742-7","volume":"23","author":"R Bargman","year":"2012","unstructured":"Bargman R, Posham R, Boskey AL, DiCarlo E, Raggio C, Pleshko N (2012) Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta. Osteoporos Int 23(3):1141\u20131150","journal-title":"Osteoporos Int"},{"key":"655_CR46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.matbio.2015.12.008","volume":"52\u201354","author":"AG Berman","year":"2016","unstructured":"Berman AG, Wallace JM, Bart ZR, Allen MR (2016) Raloxifene reduces skeletal fractures in an animal model of osteogenesis imperfecta. Matrix Biol 52\u201354:19\u201328","journal-title":"Matrix Biol"},{"issue":"5","key":"655_CR47","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/jbmr.2770","volume":"31","author":"C Shi","year":"2016","unstructured":"Shi C, Hu B, Guo L, Cao P, Tian Y, Ma J, Chen Y, Wu H, Hu J, Deng L, Zhang Y, Yuan W (2016) Strontium ranelate reduces the fracture incidence in a growing mouse model of osteogenesis imperfecta. J Bone Miner Res 31(5):1003\u20131014","journal-title":"J Bone Miner Res"},{"issue":"2","key":"655_CR48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s005860100346","volume":"11","author":"TH Smit","year":"2002","unstructured":"Smit TH (2002) The use of a quadruped as an in vivo model for the study of the spine\u2014biomechanical considerations. Eur Spine J 11(2):137\u2013144","journal-title":"Eur Spine J"},{"issue":"23","key":"655_CR49","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1097\/00007632-199512000-00015","volume":"20","author":"MJ Schendel","year":"1995","unstructured":"Schendel MJ, Dekutoski MB, Ogilvie JW, Olsewski JM, Wallace LJ (1995) Kinematics of the canine lumbar intervertebral joint. An in vivo study before and after adjacent instrumentation. Spine 20(23):2555\u20132564","journal-title":"Spine"},{"issue":"6","key":"655_CR50","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/jbmr.2172","volume":"29","author":"A Carriero","year":"2014","unstructured":"Carriero A, Zimmermann EA, Paluszny A, Tang SY, Bale H, Busse B, Alliston T, Kazakia G, Ritchie RO, Shefelbine SJ (2014) How tough is brittle bone? Investigating osteogenesis imperfecta in mouse bone. J Bone Miner Res 29(6):1392\u20131401","journal-title":"J Bone Miner Res"},{"key":"655_CR51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/B978-0-12-387829-8.00002-0","volume-title":"Genetics of bone biology and skeletal disease","author":"M Bouxsein","year":"2013","unstructured":"Bouxsein M (2013) Overview of bone structure and strength. In: Thakker R, Whyte MP, Eisman JA, Igarashi T (eds) Genetics of bone biology and skeletal disease. Elsevier Academic Press, Amsterdam, pp 25\u201334"},{"issue":"1","key":"655_CR52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1359\/jbmr.2000.15.1.13","volume":"15","author":"E Legrand","year":"2000","unstructured":"Legrand E, Chappard D, Pascaretti C, Duquenne M, Krebs S, Rohmer V, Basle MF, Audran M (2000) Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis. J Bone Miner Res 15(1):13\u201319","journal-title":"J Bone Miner Res"},{"issue":"11","key":"655_CR53","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1002\/jbmr.164","volume":"25","author":"J Wegrzyn","year":"2010","unstructured":"Wegrzyn J, Roux JP, Arlot ME, Boutroy S, Vilayphiou N, Guyen O, Delmas PD, Chapurlat R, Bouxsein ML (2010) Role of trabecular microarchitecture and its heterogeneity parameters in the mechanical behavior of ex vivo human L3 vertebrae. J Bone Miner Res 25(11):2324\u20132331","journal-title":"J Bone Miner Res"},{"issue":"1","key":"655_CR54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00198-006-0199-6","volume":"18","author":"HK Genant","year":"2007","unstructured":"Genant HK, Delmas PD, Chen P, Jiang Y, Eriksen EF, Dalsky GP, Marcus R, San Martin J (2007) Severity of vertebral fracture reflects deterioration of bone microarchitecture. Osteoporos Int 18(1):69\u201376","journal-title":"Osteoporos Int"},{"issue":"4","key":"655_CR55","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bone.2006.04.004","volume":"39","author":"C Land","year":"2006","unstructured":"Land C, Rauch F, Munns CF, Sahebjam S, Glorieux FH (2006) Vertebral morphometry in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate treatment. Bone 39(4):901\u2013906","journal-title":"Bone"},{"issue":"5","key":"655_CR56","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/jbmr.287","volume":"26","author":"BA Christiansen","year":"2011","unstructured":"Christiansen BA, Kopperdahl DL, Kiel DP, Keaveny TM, Bouxsein ML (2011) Mechanical contributions of the cortical and trabecular compartments contribute to differences in age-related changes in vertebral body strength in men and women assessed by QCT-based finite element analysis. J Bone Miner Res 26(5):974\u2013983","journal-title":"J Bone Miner Res"},{"issue":"2","key":"655_CR57","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1359\/jbmr.090803","volume":"25","author":"JP Roux","year":"2010","unstructured":"Roux JP, Wegrzyn J, Arlot ME, Guyen O, Delmas PD, Chapurlat R, Bouxsein ML (2010) Contribution of trabecular and cortical components to biomechanical behavior of human vertebrae: an ex vivo study. J Bone Miner Res 25(2):356\u2013361","journal-title":"J Bone Miner Res"},{"issue":"2","key":"655_CR58","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S8756-3282(97)00100-2","volume":"21","author":"MJ Silva","year":"1997","unstructured":"Silva MJ, Gibson LJ (1997) Modeling the mechanical behavior of vertebral trabecular bone: effects of age-related changes in microstructure. Bone 21(2):191\u2013199","journal-title":"Bone"},{"key":"655_CR59","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bonr.2018.06.008","volume":"9","author":"SM Zimmerman","year":"2018","unstructured":"Zimmerman SM, Heard-Lipsmeyer ME, Dimori M, Thostenson JD, Mannen EM, O'Brien CA, Morello R (2018) Loss of RANKL in osteocytes dramatically increases cancellous bone mass in the osteogenesis imperfecta mouse (oim). Bone Rep 9:61\u201373","journal-title":"Bone Rep"},{"key":"655_CR60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bone.2017.11.003","volume":"107","author":"G Holdsworth","year":"2018","unstructured":"Holdsworth G, Greenslade K, Jose J, Stencel Z, Kirby H, Moore A, Ke HZ, Robinson MK (2018) Dampening of the bone formation response following repeat dosing with sclerostin antibody in mice is associated with up-regulation of Wnt antagonists. Bone 107:93\u2013103","journal-title":"Bone"},{"issue":"6","key":"655_CR61","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/jbmr.2152","volume":"29","author":"MS Ominsky","year":"2014","unstructured":"Ominsky MS, Niu QT, Li C, Li X, Ke HZ (2014) Tissue-level mechanisms responsible for the increase in bone formation and bone volume by sclerostin antibody. J Bone Miner Res. 29(6):1424\u20131430","journal-title":"J Bone Miner Res."},{"issue":"2","key":"655_CR62","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jbmr.2351","volume":"30","author":"RR Recker","year":"2015","unstructured":"Recker RR, Benson CT, Matsumoto T, Bolognese MA, Robins DA, Alam J, Chiang AY, Hu L, Krege JH, Sowa H, Mitlak BH, Myers SL (2015) A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density. J Bone Miner Res 30(2):216\u2013224","journal-title":"J Bone Miner Res"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-019-00655-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-019-00655-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-019-00655-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T01:49:28Z","timestamp":1612489768000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-019-00655-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,6]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["655"],"URL":"https:\/\/doi.org\/10.1007\/s00223-019-00655-5","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,6]]},"assertion":[{"value":"27 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Michael S. Ominsky is a former employee and stockholder of Amgen. Micka\u00ebl Cardinal, Alicia Dessain, Thomas Roels, S\u00e9bastien Lafont, Jean-Pierre Devogelaer, Daniel Chappard, Guillaume Mabilleau, Patrick Ammann, Catherine Nyssen-Behets and Daniel H. Manicourt declare that they have no other conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee for Animal Care of the Universit\u00e9 Catholique de Louvain under the reference number: 2014\/UCL\/MD\/021, and conformed to the Belgian federal law for animal care.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}